US Stock MarketDetailed Quotes

NWBO Northwest Biotherapeutics

Watchlist

0.267700
-0.003800-1.40%

15min DelayTrading Nov 25 15:11 ET

347.33MMarket Cap-4461P/E (TTM)

Northwest Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

40.85%-8.23M

-40.59%-16.2M

-10.38%-12.41M

-1.63%-53.64M

-91.64%-16.96M

13.64%-13.92M

22.37%-11.52M

13.33%-11.24M

-37.80%-52.78M

21.31%-8.85M

Net income from continuing operations

17.63%-19.37M

-23.68%-17.87M

-71.91%-18.31M

40.40%-62.6M

50.61%-13.98M

28.40%-23.52M

51.30%-14.45M

25.06%-10.65M

-158.64%-105.03M

-121.23%-28.3M

Operating gains losses

433.13%8.71M

-509.59%-1.5M

182.97%2.05M

-92.83%2.05M

-79.80%2.52M

-87.07%1.63M

-91.64%365K

-160.21%-2.47M

111.92%28.51M

108.56%12.47M

Depreciation and amortization

6.75%522K

22.57%516K

25.62%505K

15.53%1.73M

10.21%421K

31.10%489K

-28.03%421K

151.25%402K

155.97%1.5M

172.86%382K

Other non cash items

-34.11%512K

-32.16%424K

12.91%682K

-10.52%2.45M

-29.19%444K

29.07%777K

-10.71%625K

-25.34%604K

-7.12%2.74M

-31.33%627K

Change In working capital

2,616.43%3.8M

-32.71%833K

6,172.22%3.28M

-151.26%-3.7M

-247.18%-5.02M

161.67%140K

-63.75%1.24M

-108.84%-54K

164.55%7.21M

590.65%3.41M

-Change in prepaid assets

-107.82%-116K

1,246.43%377K

32.72%-477K

226.20%501K

-245.98%-301K

6,279.17%1.48M

132.18%28K

-256.28%-709K

-111.42%-397K

-124.03%-87K

-Change in payables and accrued expense

381.79%3.9M

-64.64%413K

486.91%3.72M

-164.65%-4.43M

-239.68%-4.84M

-555.92%-1.38M

-66.51%1.17M

527.72%634K

1,246.73%6.85M

414.42%3.47M

-Change in other current assets

0.00%1K

-200.00%-2K

50.00%-8K

-101.92%-12K

112.50%1K

103.70%1K

110.53%2K

-102.36%-16K

449.16%625K

-142.11%-8K

-Change in other current liabilities

-55.00%18K

12.50%45K

16.22%43K

79.26%242K

237.84%125K

14.29%40K

21.21%40K

23.33%37K

419.23%135K

37.04%37K

Cash from discontinued investing activities

Operating cash flow

40.85%-8.23M

-40.59%-16.2M

-10.38%-12.41M

-1.63%-53.64M

-91.64%-16.96M

13.64%-13.92M

22.37%-11.52M

13.33%-11.24M

-37.80%-52.78M

21.31%-8.85M

Investing cash flow

Cash flow from continuing investing activities

59.73%-176K

58.29%-521K

82.07%-239K

-18.44%-3.44M

80.65%-418K

-58.33%-437K

-206.13%-1.25M

-2,198.28%-1.33M

51.75%-2.9M

-39.09%-2.16M

Net PPE purchase and sale

59.73%-176K

58.29%-521K

82.07%-239K

-18.44%-3.44M

80.65%-418K

-58.33%-437K

-206.13%-1.25M

-2,198.28%-1.33M

51.75%-2.9M

-39.09%-2.16M

Cash from discontinued investing activities

Investing cash flow

59.73%-176K

58.29%-521K

82.07%-239K

-18.44%-3.44M

80.65%-418K

-58.33%-437K

-206.13%-1.25M

-2,198.28%-1.33M

51.75%-2.9M

-39.09%-2.16M

Financing cash flow

Cash flow from continuing financing activities

-32.14%11.62M

98.40%17.14M

-3.95%12.09M

25.71%52.76M

26.99%14.42M

5.14%17.12M

-17.03%8.64M

220.97%12.58M

-12.81%41.97M

-52.04%11.35M

Net issuance payments of debt

-65.25%4.01M

835.80%9.75M

-28.28%7.1M

29,588.29%32.95M

10,670.71%10.47M

135.67%11.55M

181.09%1.04M

390.72%9.9M

-99.53%111K

-100.81%-99K

Net common stock issuance

--7.11M

----

--0

----

132.56%9.47M

--0

Net preferred stock issuance

-94.81%267K

81.78%4.31M

51.95%3.62M

-28.60%13.33M

-55.81%3.43M

-52.83%5.14M

--2.37M

--2.39M

--18.67M

--7.77M

Proceeds from stock option exercised by employees

-18.75%26K

-86.34%180K

428.63%1.31M

-84.61%1.72M

-89.37%119K

-93.36%32K

-75.46%1.32M

-94.07%248K

-44.15%11.16M

-85.78%1.12M

Net other financing activities

-50.00%200K

--0

0.00%50K

85.39%4.76M

--400K

--3.91M

--50K

926.40%2.57M

----

Cash from discontinued financing activities

Financing cash flow

-32.14%11.62M

98.40%17.14M

-3.95%12.09M

25.71%52.76M

26.99%14.42M

5.14%17.12M

-17.03%8.64M

220.97%12.58M

-12.81%41.97M

-52.04%11.35M

Net cash flow

Beginning cash position

102.32%2.88M

-59.97%2.48M

-69.48%2.13M

-54.08%6.97M

-35.31%6.1M

-70.52%1.42M

-11.09%6.19M

-54.08%6.97M

51.95%15.17M

145.70%9.43M

Current changes in cash

16.05%3.21M

110.16%420K

-5,700.00%-560K

68.52%-4.32M

-965.79%-2.96M

2,662.04%2.77M

14.59%-4.13M

100.11%10K

-459.06%-13.71M

-96.85%342K

Effect of exchange rate changes

-265.42%-3.15M

97.32%-17K

216.33%912K

-109.50%-523K

63.95%-1.01M

-59.46%1.91M

-123.47%-635K

-187.21%-784K

302.41%5.51M

-706.49%-2.8M

End cash Position

-51.80%2.94M

102.32%2.88M

-59.97%2.48M

-69.48%2.13M

-35.31%6.1M

-70.52%1.42M

-11.09%6.19M

-54.08%6.97M

Free cash flow

41.43%-8.41M

-30.92%-16.72M

-0.58%-12.65M

-2.51%-57.07M

-57.83%-17.38M

12.43%-14.36M

16.26%-12.77M

3.48%-12.57M

-25.64%-55.68M

13.99%-11.01M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	40.85%-8.23M	-40.59%-16.2M	-10.38%-12.41M	-1.63%-53.64M	-91.64%-16.96M	13.64%-13.92M	22.37%-11.52M	13.33%-11.24M	-37.80%-52.78M	21.31%-8.85M
Net income from continuing operations	17.63%-19.37M	-23.68%-17.87M	-71.91%-18.31M	40.40%-62.6M	50.61%-13.98M	28.40%-23.52M	51.30%-14.45M	25.06%-10.65M	-158.64%-105.03M	-121.23%-28.3M
Operating gains losses	433.13%8.71M	-509.59%-1.5M	182.97%2.05M	-92.83%2.05M	-79.80%2.52M	-87.07%1.63M	-91.64%365K	-160.21%-2.47M	111.92%28.51M	108.56%12.47M
Depreciation and amortization	6.75%522K	22.57%516K	25.62%505K	15.53%1.73M	10.21%421K	31.10%489K	-28.03%421K	151.25%402K	155.97%1.5M	172.86%382K
Other non cash items	-34.11%512K	-32.16%424K	12.91%682K	-10.52%2.45M	-29.19%444K	29.07%777K	-10.71%625K	-25.34%604K	-7.12%2.74M	-31.33%627K
Change In working capital	2,616.43%3.8M	-32.71%833K	6,172.22%3.28M	-151.26%-3.7M	-247.18%-5.02M	161.67%140K	-63.75%1.24M	-108.84%-54K	164.55%7.21M	590.65%3.41M
-Change in prepaid assets	-107.82%-116K	1,246.43%377K	32.72%-477K	226.20%501K	-245.98%-301K	6,279.17%1.48M	132.18%28K	-256.28%-709K	-111.42%-397K	-124.03%-87K
-Change in payables and accrued expense	381.79%3.9M	-64.64%413K	486.91%3.72M	-164.65%-4.43M	-239.68%-4.84M	-555.92%-1.38M	-66.51%1.17M	527.72%634K	1,246.73%6.85M	414.42%3.47M
-Change in other current assets	0.00%1K	-200.00%-2K	50.00%-8K	-101.92%-12K	112.50%1K	103.70%1K	110.53%2K	-102.36%-16K	449.16%625K	-142.11%-8K
-Change in other current liabilities	-55.00%18K	12.50%45K	16.22%43K	79.26%242K	237.84%125K	14.29%40K	21.21%40K	23.33%37K	419.23%135K	37.04%37K
Cash from discontinued investing activities
Operating cash flow	40.85%-8.23M	-40.59%-16.2M	-10.38%-12.41M	-1.63%-53.64M	-91.64%-16.96M	13.64%-13.92M	22.37%-11.52M	13.33%-11.24M	-37.80%-52.78M	21.31%-8.85M
Investing cash flow
Cash flow from continuing investing activities	59.73%-176K	58.29%-521K	82.07%-239K	-18.44%-3.44M	80.65%-418K	-58.33%-437K	-206.13%-1.25M	-2,198.28%-1.33M	51.75%-2.9M	-39.09%-2.16M
Net PPE purchase and sale	59.73%-176K	58.29%-521K	82.07%-239K	-18.44%-3.44M	80.65%-418K	-58.33%-437K	-206.13%-1.25M	-2,198.28%-1.33M	51.75%-2.9M	-39.09%-2.16M
Cash from discontinued investing activities
Investing cash flow	59.73%-176K	58.29%-521K	82.07%-239K	-18.44%-3.44M	80.65%-418K	-58.33%-437K	-206.13%-1.25M	-2,198.28%-1.33M	51.75%-2.9M	-39.09%-2.16M
Financing cash flow
Cash flow from continuing financing activities	-32.14%11.62M	98.40%17.14M	-3.95%12.09M	25.71%52.76M	26.99%14.42M	5.14%17.12M	-17.03%8.64M	220.97%12.58M	-12.81%41.97M	-52.04%11.35M
Net issuance payments of debt	-65.25%4.01M	835.80%9.75M	-28.28%7.1M	29,588.29%32.95M	10,670.71%10.47M	135.67%11.55M	181.09%1.04M	390.72%9.9M	-99.53%111K	-100.81%-99K
Net common stock issuance	--7.11M	----	----	--0	--0	--0	----	----	132.56%9.47M	--0
Net preferred stock issuance	-94.81%267K	81.78%4.31M	51.95%3.62M	-28.60%13.33M	-55.81%3.43M	-52.83%5.14M	--2.37M	--2.39M	--18.67M	--7.77M
Proceeds from stock option exercised by employees	-18.75%26K	-86.34%180K	428.63%1.31M	-84.61%1.72M	-89.37%119K	-93.36%32K	-75.46%1.32M	-94.07%248K	-44.15%11.16M	-85.78%1.12M
Net other financing activities	-50.00%200K	--0	0.00%50K	85.39%4.76M	--400K	--400K	--3.91M	--50K	926.40%2.57M	----
Cash from discontinued financing activities
Financing cash flow	-32.14%11.62M	98.40%17.14M	-3.95%12.09M	25.71%52.76M	26.99%14.42M	5.14%17.12M	-17.03%8.64M	220.97%12.58M	-12.81%41.97M	-52.04%11.35M
Net cash flow
Beginning cash position	102.32%2.88M	-59.97%2.48M	-69.48%2.13M	-54.08%6.97M	-35.31%6.1M	-70.52%1.42M	-11.09%6.19M	-54.08%6.97M	51.95%15.17M	145.70%9.43M
Current changes in cash	16.05%3.21M	110.16%420K	-5,700.00%-560K	68.52%-4.32M	-965.79%-2.96M	2,662.04%2.77M	14.59%-4.13M	100.11%10K	-459.06%-13.71M	-96.85%342K
Effect of exchange rate changes	-265.42%-3.15M	97.32%-17K	216.33%912K	-109.50%-523K	63.95%-1.01M	-59.46%1.91M	-123.47%-635K	-187.21%-784K	302.41%5.51M	-706.49%-2.8M
End cash Position	-51.80%2.94M	102.32%2.88M	-59.97%2.48M	-69.48%2.13M	-69.48%2.13M	-35.31%6.1M	-70.52%1.42M	-11.09%6.19M	-54.08%6.97M	-54.08%6.97M
Free cash flow	41.43%-8.41M	-30.92%-16.72M	-0.58%-12.65M	-2.51%-57.07M	-57.83%-17.38M	12.43%-14.36M	16.26%-12.77M	3.48%-12.57M	-25.64%-55.68M	13.99%-11.01M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data